Albert Bourla, commonly known as A. Bourla, is a prominent figure in the pharmaceutical industry, serving as the Chairman and Chief Executive Officer of Pfizer Inc. Born in Thessaloniki, Greece, Bourla earned a doctorate in the veterinary medicine from Aristotle University of Thessaloniki’s Veterinary School. He furthered his education with a master’s degree in Business Administration from the City University of New York. Bourla's career at Pfizer began in 1993, and over the years, he has held numerous leadership positions within the company, including President and General Manager of Pfizer's Established Products Business Unit, Group President of Pfizer's Global Established Pharmaceutical and Global Vaccines, and Chief Operating Officer before ascending to the role of CEO in 2019. Under Bourla's leadership, Pfizer has experienced significant achievements, most notably during the global response to the COVID-19 pandemic. Bourla spearheaded the development and distribution of the Pfizer-BioNTech COVID-19 vaccine, a monumental effort that has been recognized worldwide for its role in combating the virus. Beyond the vaccine, he has driven Pfizer's broader strategy towards becoming a more innovative and science-driven company, focusing on breakthroughs in oncology, rare diseases, and internal medicine. His vision for Pfizer includes a commitment to health equity and ensuring that the company's innovations reach underserved populations globally. As Chairman and CEO, Bourla plays a pivotal role in steering Pfizer's strategic direction and fostering a culture of innovation and excellence. His leadership style emphasizes transparency, collaboration, and a relentless focus on patient outcomes. Bourla is also actively involved in various industry and community initiatives, serving on the boards of The Pfizer Foundation, the Partnership for New York City, and the Pharmaceutical Research and Manufacturers of America (PhRMA). His contributions to the pharmaceutical sector have earned him numerous accolades, including being named one of the "World's 50 Greatest Leaders" by Fortune magazine in 2021.